ERBB2 and breast carcinoma: Expression of exogenous HER2 in normal mammary stem cell populations generated hyperplastic lesions when transplanted in vivo [13], and in breast cancer cells HER2 expression enhanced the occurrence of side-populations of tumor-initiating cells of the luminal subtype and is clinically correlated with cancer stem cell populations [12,13,17].